Evaluation of AKR1B10 as a New Marker for Interventional Therapy of Hepatocellular Carcinoma

NCT06272656 · clinicaltrials.gov ↗
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Hebei Medical University Third Hospital